AnaptysBio, Inc. (ANAB)
57.68
+0.95
(+1.67%)
USD |
NASDAQ |
Apr 02, 16:00
57.92
+0.24
(+0.42%)
After-Hours: 20:00
AnaptysBio Shareholders Equity (Quarterly) : 37.21M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 477.32M |
| Nektar Therapeutics | 89.83M |
| Rigel Pharmaceuticals, Inc. | 391.48M |
| Vanda Pharmaceuticals, Inc. | 327.19M |
| Adaptive Biotechnologies Corp. | 218.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.40M |
| Total Liabilities (Quarterly) | 327.18M |
| Debt to Equity Ratio | 7.811 |
| Current Ratio | 9.068 |
| Net Debt Paydown Yield | 1.13% |